Donald J. Trump @reallDonaldTrump twitted: “Scott Gottlieb, who has done an absolutely terrific job as Commissioner of the FDA, plans to leave government service sometime next month…. ….Scott has helped us to lower drug prices, get a record number of generic drugs . . . Continue reading →
A gangbusters investigative report by Science Magazine (July 2018) documents FDA’s disregard of substantial financial conflicts of interest by the advisory panel members that FDA selects. What’s more, the reporters uncovered a previously overlooked stream of company kickbacks to doctors on FDA advisory . . . Continue reading →
In 2003, the Veterans Affairs ordered a 90-day national “stand down” for all human subject research activities “in response to the death of subjects”; as well as use of “unqualified researchers.” In January 2004, the Director of Defense Research and Engineering (DDR&E) initiated . . . Continue reading →
Lots of babies get measles in Africa and India, and it is a significant cause of death there. A great deal of work has gone into developing measles vaccines that can be given to children at younger and younger ages, especially in . . . Continue reading →
Anthrax Vaccine: Its checkered history, excessive stockpile and the human and financial costs By Meryl Nass, MD* The current vaccine (Biothrax, manufactured by Emergent Biosolutions or EBS) has never been proved effective in humans. One human trial took place in the 1950s . . . Continue reading →
Bloomberg News conducted a data review of payroll records for 1.4 million public employees of the 12 largest states. The findings show that public employees in California earn far higher salaries than in other states, from prison operations to health care, base . . . Continue reading →
Physicians at Sloan Kettering Cancer Center have taken a giant step toward stemming the tide of unconscionable pharmaceutical industry price gouging. Sloan-Kettering physicians said NO to Sanofi’s new anti-cancer drug, Zaltrap which the company priced at $11,063 per month. Drs. Peter B. . . . Continue reading →
Respected international scientists who examined the evidence, concluded that annual influenza campaigns are likely an utter waste of time and money." But officials at the US Centers for Disease Control disregard science and accept commercial propaganda as their guide for setting public health policy.
Continue reading →
Part III. The Untouchable Third Rail in Healthcare—The Vaccine Controversy: Core Issues Continue reading →
Part II. What Do We Get for All That Money? A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic; Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;
“The law says veterans have the right to due process.But when the fiduciary process is initiated, that all goes out the window.” Continue reading →
The FDA granted market exclusivity to KV for an old drug that had been available from special pharmacies that custom-compound treatments not approved by the FDA, for $20 a shot. By granting KV market exclusivity, women could no longer obtain the drug, Makena, at a reasonable price– KV set the price at $1,500 a shot. Continue reading →